Author: Minichart

us corporate news

Arq, Inc. 2025 Annual Report: Environmental Technology, Activated Carbon Solutions, Risk Factors, and Cybersecurity Practices

Minichart

March 10, 2026

Arq, Inc. 2025 Annual Report: Key Highlights and Investor In...

Continue Reading 0

us corporate news

Trailblazer Merger Corporation I (TBMC) 2025 Annual Report: Business Strategy, SPAC Merger with Cyabra, and Technology Industry Focus

Minichart

March 10, 2026

Trailblazer Merger Corp I 2025 Annual Report: Key Investor I...

Continue Reading 0

us corporate news

Lipocine Inc. 2025 Annual Report: Innovative Oral Drug Delivery, CNS & Metabolic Pipeline, and R&D Highlights

Minichart

March 10, 2026

Lipocine Inc. 2025 Annual Report: Key Highlights for Investo...

Continue Reading 0

SGX corporate News

Annica Holdings Withdraws Proposed Share Consolidation Announcement and Plans Revised Terms – March 2026 1

Minichart

March 10, 2026

Annica Holdings Limited Withdraws Proposed Share Consolidati...

Continue Reading 0

us corporate news

Custom Truck One Source, Inc. 2025 Annual Report: Specialty Equipment Rentals, Sales, and Market Growth Strategies

Minichart

March 10, 2026

Custom Truck One Source, Inc. 2025 Annual Report – Key Insig...

Continue Reading 0

SGX corporate News

Annica Holdings Withdraws Proposed Rights Issue Following SGX RegCo Consultation – Revised Terms Announced 1

Minichart

March 10, 2026

Annica Holdings Withdraws Proposed Rights Issue: Key Details...

Continue Reading 0

us corporate news

Q32 Bio Inc. 2025 Annual Report: Business Overview, Pipeline, Risks, and Intellectual Property Strategies

Minichart

March 10, 2026

Q32 Bio Inc. 2025 Annual Report: Key Highlights and Investor...

Continue Reading 0

SGX corporate News

Mapletree Industrial Trust Discloses S$3.25 Billion Debt Facility Conditions Under SGX Rule 704(31)

Minichart

March 10, 2026

Mapletree Industrial Trust Announces New Loan Facility with ...

Continue Reading 0

us corporate news

Rapport Therapeutics: Advancing Precision Neuroscience with RAP Technology Platform for Neurological and Psychiatric Disorders 4048

Minichart

March 10, 2026

Rapport Therapeutics 2025 Annual Report: Key Investor Takeaw...

Continue Reading 0

us corporate news

Cullinan Therapeutics 2025 10-K: Advancing First-in-Class Therapies for Autoimmune Diseases and Cancer, Risks, and Strategic Developments

Minichart

March 10, 2026

Cullinan Therapeutics, Inc. 2025 10-K: Key Highlights for In...

Continue Reading 0